Optimized 3D-FLAIR sequences to shorten the delay between intravenous administration of gadolinium and MRI acquisition in patients with Menière's disease.
Juliette BarletAlexis VaussyYohan EjzenbergMichel ToupetCharlotte HautefortAndré GillibertArnaud AttyéMichael EliezerPublished in: European radiology (2022)
Clinical trial no: 38RC15.173 KEY POINTS: • Magnetic resonance imaging with delayed 3D-FLAIR sequences allows the diagnosis of endolymphatic hydrops in patients with definite Menière's disease. • An optimized 3D-FLAIR sequence with a long TR of 16000 ms and a constant flip angle allows for reducing the delay between intravenous injection of gadobutrol and MRI acquisition from 4 to 2 h to diagnose endolymphatic hydrops. • Reducing this delay between intravenous injection and MRI acquisition could have implications for clinical practice for both patients and imaging departments.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- clinical trial
- diffusion weighted imaging
- high dose
- computed tomography
- end stage renal disease
- clinical practice
- high resolution
- magnetic resonance
- ejection fraction
- chronic kidney disease
- newly diagnosed
- multiple sclerosis
- mass spectrometry
- ultrasound guided
- prognostic factors
- ms ms
- study protocol
- randomized controlled trial
- phase ii